Usefulness of mycophenolate mofetil in Indian patients with C3 glomerulopathy

BACKGROUND: C3 glomerulopathy (C3G) is a heterogeneous disease caused by alternative complement pathway abnormalities without any standardized treatment. An immunosuppressive agent, mycophenolate mofetil (MMF), has been recently shown to be useful in treating C3G, mainly in studies from the west. We...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Kidney J
Päätekijät: Bharati, Joyita, Tiewsoh, Karalanglin, Kumar, Ashwani, Nada, Ritambhra, Rathi, Manish, Gupta, Krishan Lal, Kohli, Harbir Singh, Jha, Vivekananda, Ramachandran, Raja
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
C3 Glomerulopathy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6671524/
https://ncbi.nlm.nih.gov/pubmed/31384438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfy127
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia